dehydroemetine

Dehydroemetine is a synthetically produced antiprotozoal agent similar to emetine in its anti-amoebic properties and structure (they differ only in a double bond next to the ethyl substituent), but it produces fewer side effects. In the United States, it is manufactured by Roche.

Its exact mechanism is not known, but in vitro it inhibits translocation.

It was at one-time, but is no longer distributed by the Center for Disease Control on a compassionate use basis as an investigational drug for the ...